433 related articles for article (PubMed ID: 12418050)
1. Primary prevention: phytoprevention and chemoprevention of colorectal cancer.
Turini ME; DuBois RN
Hematol Oncol Clin North Am; 2002 Aug; 16(4):811-40. PubMed ID: 12418050
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
[TBL] [Abstract][Full Text] [Related]
3. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
Reddy BS; Rao CV
J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
[TBL] [Abstract][Full Text] [Related]
5. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
6. Screening for colon cancer and evaluation of chemoprevention with coxibs.
Rex DK
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S41-50. PubMed ID: 11992750
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs and chemoprevention.
Rao CV; Reddy BS
Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colorectal cancer: dietary and pharmacologic approaches.
Garay CA; Engstrom PF
Oncology (Williston Park); 1999 Jan; 13(1):89-97; discussion 97-100, 105. PubMed ID: 10027203
[TBL] [Abstract][Full Text] [Related]
10. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
[TBL] [Abstract][Full Text] [Related]
11. Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs.
Reddy BS; Rao CV
Drugs Aging; 2000 May; 16(5):329-34. PubMed ID: 10917070
[TBL] [Abstract][Full Text] [Related]
12. The role of cyclooxygenase inhibitors in cancer prevention.
Anderson WF; Umar A; Viner JL; Hawk ET
Curr Pharm Des; 2002; 8(12):1035-62. PubMed ID: 11945150
[TBL] [Abstract][Full Text] [Related]
13. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents.
Nardone G; Rocco A
Dig Dis; 2004; 22(4):320-6. PubMed ID: 15812154
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colorectal cancer.
Das D; Arber N; Jankowski JA
Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
[TBL] [Abstract][Full Text] [Related]
16. The future of colon cancer prevention.
Umar A; Viner JL; Hawk ET
Ann N Y Acad Sci; 2001 Dec; 952():88-108. PubMed ID: 11795446
[TBL] [Abstract][Full Text] [Related]
17. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Curr Top Med Chem; 2005; 5(5):517-25. PubMed ID: 15974946
[TBL] [Abstract][Full Text] [Related]
19. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
